Avid Bioservices Current Ratio 2006-2021 | CDMO

Avid Bioservices current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Avid Bioservices Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-07-31 $0.20B $0.06B 3.17
2021-04-30 $0.21B $0.07B 2.93
2021-01-31 $0.12B $0.06B 1.86
2020-10-31 $0.06B $0.04B 1.45
2020-07-31 $0.06B $0.04B 1.50
2020-04-30 $0.06B $0.04B 1.34
2020-01-31 $0.06B $0.04B 1.57
2019-10-31 $0.06B $0.03B 1.67
2019-07-31 $0.05B $0.03B 1.78
2019-04-30 $0.05B $0.02B 2.22
2019-01-31 $0.05B $0.02B 2.34
2018-10-31 $0.05B $0.02B 2.26
2018-07-31 $0.06B $0.03B 2.21
2018-04-30 $0.07B $0.04B 1.79
2018-01-31 $0.04B $0.04B 1.13
2017-10-31 $0.05B $0.03B 1.46
2017-07-31 $0.07B $0.04B 1.67
2017-04-30 $0.09B $0.06B 1.43
2017-01-31 $0.08B $0.07B 1.19
2016-10-31 $0.08B $0.07B 1.25
2016-07-31 $0.08B $0.06B 1.24
2016-04-30 $0.08B $0.06B 1.42
2016-01-31 $0.09B $0.06B 1.61
2015-10-31 $0.09B $0.04B 2.11
2015-07-31 $0.07B $0.04B 2.04
2015-04-30 $0.08B $0.04B 2.16
2015-01-31 $0.07B $0.03B 2.43
2014-10-31 $0.07B $0.02B 3.45
2014-07-31 $0.08B $0.02B 3.86
2014-04-30 $0.09B $0.02B 3.86
2014-01-31 $0.07B $0.02B 3.48
2013-10-31 $0.05B $0.02B 2.73
2013-07-31 $0.05B $0.02B 2.50
2013-04-30 $0.04B $0.02B 2.04
2013-01-31 $0.03B $0.02B 1.80
2012-10-31 $0.03B $0.02B 1.44
2012-07-31 $0.03B $0.03B 1.05
2012-04-30 $0.03B $0.02B 1.41
2012-01-31 $0.03B $0.02B 1.70
2011-10-31 $0.02B $0.01B 1.77
2011-07-31 $0.02B $0.01B 1.67
2011-04-30 $0.03B $0.02B 1.74
2011-01-31 $0.03B $0.02B 1.91
2010-10-31 $0.03B $0.02B 1.62
2010-07-31 $0.03B $0.02B 1.74
2010-04-30 $0.03B $0.01B 1.91
2010-01-31 $0.03B $0.01B 1.92
2009-10-31 $0.03B $0.02B 1.43
2009-07-31 $0.02B $0.02B 1.29
2009-04-30 $0.02B $0.02B 1.07
2009-01-31 $0.02B $0.02B 1.29
2008-10-31 $0.02B $0.02B 1.22
2008-07-31 $0.02B $0.01B 1.64
2008-04-30 $0.02B $0.01B 2.67
2008-01-31 $0.03B $0.01B 3.72
2007-10-31 $0.03B $0.01B 4.50
2007-07-31 $0.04B $0.01B 6.98
2007-04-30 $0.02B $0.01B 3.40
2007-01-31 $0.03B $0.01B 4.17
2006-10-31 $0.03B $0.01B 5.64
2006-07-31 $0.03B $0.00B 7.87
2006-04-30 $0.02B $0.00B 4.49
2006-01-31 $0.02B $0.00B 4.67
2005-10-31 $0.02B $0.00B 3.71
2005-07-31 $0.02B $0.00B 5.09
2005-04-30 $0.01B $0.00B 2.92
2005-01-31 $0.01B $0.00B 3.02
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.595B $0.096B
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It also offer process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. Avid Bioservices Inc., formerly known as Peregrine Pharmaceuticals Inc., is based in TUSTIN, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76